Pharma Co. Investors Ink $4M Deal In FDA Hurdle Suit
Verrica Pharmaceuticals and a group of investors have reached a $4 million deal to end claims that the company hid obstacles it faced in obtaining U.S. Food and Drug Administration approval...To view the full article, register now.
Already a subscriber? Click here to view full article